Cell Free DNA Testing for Myocarditis
Recruiting0 awards14 criteria
Iowa City, Iowa
This trial is looking at a potential new way to diagnose active myocarditis (inflammation of the heart) in patients with sarcoidosis. The current method for diagnosing active myocarditis is limited and this trial is exploring whether cell free DNA (fragments of genomic DNA that are released into the circulation from dying or damaged cells) can be used as a biomarker to more accurately diagnose active myocarditis.
Corticosteroid
Acthar Gel for Sarcoidosis
Recruiting5 awardsPhase 4
San Francisco, California
This trial is testing Acthar gel, a medication that reduces inflammation, in patients with pulmonary sarcoidosis. The goal is to see if it improves lung function and symptoms by calming the immune system. Researchers will also check if certain blood markers decrease as symptoms improve.
Popular Filters
Trials With No Placebo
Janus Kinase (JAK) Inhibitor
Baricitinib for Cardiac Sarcoidosis
Recruiting1 awardPhase 2
Palo Alto, California
This trial aims to see if using a medication called baricitinib along with another medication can help treat a condition called active cardiac sarcoidosis in adults. The trial will investigate if baricitin
Tyrosine Kinase Inhibitor
Deucravacitinib for Sarcoidosis and Granuloma Annulare
Recruiting1 awardPhase 2
New Haven, Connecticut
This trial aims to study the use of an oral medication that targets a specific protein in patients with a skin condition called sarcoidosis. The trial focuses on patients with moderate to severe sarcoidosis that
Janus Kinase Inhibitor
Abrocitinib for Sarcoidosis
Recruiting1 awardPhase 2
New Haven, Connecticut
This trial is testing a new pill called abrocitinib for patients with moderate to severe skin sarcoidosis. The pill aims to reduce inflammation by targeting a specific protein in the immune system. Researchers hope this will improve skin lesions better than current treatments.
Prostacyclin Analogue
Inhaled Treprostinil for Sarcoidosis
Recruiting1 awardPhase 2
Gainesville, Florida
This trial is testing an inhaled medication called treprostinil for people with a specific lung disease (sarcoidosis) that causes high blood pressure in the lungs. The treatment aims to help these patients breathe better and exercise more easily by widening their lung blood vessels. The study will also check if this treatment is safe for them. Inhaled treprostinil has been shown to improve exercise tolerance and has demonstrated safety and beneficial effects on hemodynamics, exercise capacity, and quality of life.
Corticosteroid
Prednisone/Prednisolone Dosing for Cardiac Sarcoidosis
Recruiting4 awardsPhase 3
New Haven, Connecticut
This trial is comparing the effectiveness of two different doses of Prednisone (or Prednisolone), one standard and one low, in patients with cardiac sarcoidosis who have not yet been treated. The Investigators hypothesize that the low dose will be just as effective as the standard dose, but with better quality of life and less toxicity.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.